General MedicationsINTRAVENOUSStandard
SODIUM ACETATE
SODIUM ACETATE
Standard Dose
40MEQ/20ML (2MEQ/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview SODIUM ACETATE is listed in Drugs@FDA under application 018893 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM ACETATE Form and strength SOLUTION;INTRAVENOUS - 40MEQ/20ML (2MEQ/ML) Sponsor HOSPIRA Submission history Latest submission status date: 2014-09-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview SODIUM ACETATE is listed in Drugs@FDA under application 018893 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM ACETATE Form and strength SOLUTION;INTRAVENOUS - 40MEQ/20ML (2MEQ/ML) Sponsor HOSPIRA Submission history Latest submission status date: 2014-09-02 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.